Introduction
so that its usefulness is reduced to an encyclopedic nature, i.e., to be consulted when full details are needed. In a standard textbook of pharmacology [1] there are 50
As a result, the only practical classification of antiar-(three-column, 69-line) pages in the index (50333695 rhythmic agents that has survived the second millennium is 10 350). In order to render this vast information somewhat that proposed by Vaughan Williams [4] . manageable the chemicals are grouped in about 50 chapters, one of which is ''Agents used in cardiac arrhythmias'' [2] . Antiarrhythmic agents are in turn subdivided in four 2. Class I classes plus a group of miscellaneous agents (containing those that do not fit in any of the four standard classes). At
These are agents that block sodium channels as their times it is desirable to subdivide these classes into subclasprimary mechanism of action. As a result, they depress the ses (main topic of this paper).ḿ aximum rate of rise (y ) of the cardiac action potential max Although such classification renders the pharmacologi-(AP) and slow conduction through the His-Purkinje cal information more manageable, it is frequently difficult system as well as the atrial and ventricular myocardium. or impossible to fit a chemical in a class. For example, However, the depressant actions of these agents vary quite while beta blockers certainly belong as a chapter in the widely, so that Hoffman and Bigger [5] divided them into section on autonomic drugs, they also form an important two subclasses: (A) depresses conduction and lengthens the class in the antiarrhythmic agents (see below). In addition, AP duration (APD), while (B) has little effect or actually they also need to be described in the sections on angina, increases conduction and shortens the APD. In the eighties congestive heart failure and hypertension (among others).
some new sodium channel blockers were introduced that This problem follows directly from the first law of were much more potent in depressing conduction, but they pharmacology: no drug has a single effect.
did very little to APD. So, it was deemed necessary to A group of investigators has tried to remedy this introduce a new subclass: class I [6] .
C problem for classification of antiarrhythmic agents by Campbell [7] noted that the class I agents differed from C proposing an alternative: the Sicilian gambit [3] . Basically, the other class I drugs: they list all the chemicals with antiarrhythmic properties as rows in a 
Class II
These are agents that act by blocking b-receptors. This mechanism is the only antiarrhythmic action that has been documented to be effective in prolonging life [9] and thereby is the only class that has satisfied the second law of pharmacology: primum non nocere. Indeed, class I (CAST [10]) and class III (SWORD [11] ) agents have been shown to cause excess mortality in patients where a benefit was expected. While for class IV agents the large trials are still in progress, there certainly exist warning flags against their general wide spread use [12] . In 1977, Hondeghem and Katzung [8] described the While these agents usually lengthen the APD at normal molecular mechanisms of how sodium channel blocking and slow heart rates, the prolongation frequently declines antiarrhythmic agents interact with their receptor (moduas the cycle length is reduced. As a result, the prolongation lated receptor theory). Briefly, during each upstroke and / of APD is marked when it is not needed, but vanishes or plateau block develops, while during diastole unblockduring tachycardia: reverse use-dependence (Fig. 2) . Foling proceeds. Hence, if recovery from block is slow, then lowing long cycle lengths the prolongation of the APD can during a normal diastolic interval there can be only little be so excessive that repolarization disturbances occur: recovery. For this reason there can be only little block hesitation of repolarization, EADs, torsades de pointes and during the AP, otherwise accumulation of block would lead fibrillation. In addition, reverse use-dependence induces to toxicity. However, if recovery from block is fast, then instability of APD: following an ectopic, the next diastolic there can be much more unblocking during diastole . . . interval is shorter or longer (compensatory pause). Reverse and much more block during the AP is also permissible.
use-dependence shortens the APD following a short diasBy these mechanisms Campbell reasoned that fast recovertolic interval. But, at a given cycle length, a shorter APD AB leads to a longer diastolic interval, which in turn provides classes of antiarrhythmic action: not only does it lengthen for a longer APD followed by a shorter diastole, etc., APD (class III), it also blocks sodium channels (class I), etc., . . . in this way reverse use-dependence leads to APD has antiadrenergic actions (class II) and blocks calcium alternans and chaos. As a result these agents have been channels (class IV). The sodium and calcium channel predicted and observed [11, 13] to have a low efficacy and block may help prevent repolarization disturbances (during to be proarrhythmic. I have proposed that the class III crossing of the calcium and sodium window currents), agents which act primarily during bradycardia be grouped while the antiadrenergic effect may contribute to its ] as class III [15] . general beneficial effect. These are agents that act by blocking calcium channels. effective refractory period exceeds the cycle length of the Similar to sodium channel blockers, these agents bind tachycardia, i.e., rendering continuation of the tachycardia preferentially during the upstroke and / or the plateau of the impossible. I have suggested that agents which act primaricardiac AP while they unblock primarily during diastole ly upon acceleration of the heart would be classified as [16] . Similar to the proposal by Campbell [7] Of all the class III antiarrhythmic agents, amiodarone dihydropyridine calcium channel blocking agents) have appears to have the greatest efficacy and appears to trigger little antiarrhythmic activity, because their dissociation rate the least torsades de pointes. It is also the agent that constant from cardiac calcium channels is so short that lengthens the APD about equally well at short as at long little drug remains on the receptors by the end of diastole. cycle lengths, hence class III . Maintenance of the AB prolongation during tachycardia renders the agent more effective, while not excessively prolonging the APD 6. Conclusion following long cycle lengths reduces the likelihood of proarrhythmia.
Kinetic aspects of interactions of antiarrhythmic agents As noted above, no drug has a single effect, this is with their ion channels, as pointed out by Campbell [7] , especially true for amiodarone that belongs to all four are clearly important in the classification, understanding
